We are live on
!
Find out more
BM
Brandywine Managers Portfolio holdings
AUM
$170M
1-Year Est. Return
10.01%
This Fund
S&P 500
This Quarter
Est. Return
-1.62%
1 Year Est. Return
+10.01%
3 Year Est. Return
+53.1%
5 Year Est. Return
+7.42%
10 Year Est. Return
+248.69%
AUM
$59.3M
AUM Growth
-$92.2M
(-61%)
Cap. Flow
-$90.6M
Cap. Flow
% of AUM
-152.84%
Top 10 Holdings %
Top 10 Hldgs %
76.36%
Holding
49
New
1
Increased
2
Reduced
1
Closed
11
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$1.65M |
| 2 |
UiPath
PATH
|
+$694K |
| 3 |
Structure Therapeutics
GPCR
|
+$354K |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$23.9M |
| 2 |
Philip Morris
PM
|
+$20.2M |
| 3 |
Automatic Data Processing
ADP
|
+$11.7M |
| 4 |
Starbucks
SBUX
|
+$10.7M |
| 5 |
Keurig Dr Pepper
KDP
|
+$9.15M |
Sector Composition
| 1 | Technology | 46.81% |
| 2 | Healthcare | 13.72% |
| 3 | Consumer Staples | 1.66% |
| 4 | Financials | 1.19% |
| 5 | Consumer Discretionary | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI ACWI ETF
ACWI
$32.8B
| $20.9M | 35.35% |
226,783
+17,165
| +8% | +$1.65M |
|
|
2
UiPath
PATH
$6.3B
| $11.2M | 18.87% |
653,456
+41,692
| +7% | +$694K |
|
3
CrowdStrike
CRWD
$207B
| $4.8M | 8.1% |
114,720
| – | – |
|
4
NVIDIA
NVDA
$4.91T
| $1.55M | 2.62% |
35,640
| – | – |
|
5
Salesforce
CRM
$140B
| $1.4M | 2.37% |
6,913
| – | – |
|
6
Uber
UBER
$147B
| $1.23M | 2.08% |
26,740
| – | – |
|
7
Zscaler
ZS
$24.2B
| $1.15M | 1.94% |
7,407
| – | – |
|
8
Intuitive Surgical
ISRG
$122B
| $1.02M | 1.72% |
3,495
| – | – |
|
9
Campbell Soup
CPB
$6.58B
| $986K | 1.66% |
24,014
| – | – |
|
10
Moderna
MRNA
$24.5B
| $982K | 1.66% |
9,510
| – | – |
|
11
Palo Alto Networks
PANW
$292B
| $869K | 1.47% |
7,410
| – | – |
|
12
Okta
OKTA
$26B
| $835K | 1.41% |
10,248
| – | – |
|
13
Natera
NTRA
$38.9B
| $820K | 1.38% |
18,534
-3,000
| -14% | -$153K |
|
14
Alnylam Pharmaceuticals
ALNY
$35.7B
| $816K | 1.38% |
4,608
| – | – |
|
15
Veeva Systems
VEEV
$31.7B
| $797K | 1.35% |
3,919
| – | – |
|
16
Advanced Micro Devices
AMD
$808B
| $750K | 1.27% |
7,299
| – | – |
|
17
Mastercard
MA
$480B
| $707K | 1.19% |
1,785
| – | – |
|
18
PagerDuty
PD
$794M
| $686K | 1.16% |
30,517
| – | – |
|
19
Datadog
DDOG
$92.1B
| $656K | 1.11% |
7,200
| – | – |
|
20
Samsara
IOT
$22.3B
| $594K | 1% |
23,578
| – | – |
|
21
Schrodinger
SDGR
$1.14B
| $590K | 1% |
20,886
| – | – |
|
22
Twilio
TWLO
$31.4B
| $573K | 0.97% |
9,782
| – | – |
|
|
23
Structure Therapeutics
GPCR
$3.45B
| $555K | 0.94% |
+11,000
| New | +$354K |
|
24
Mobileye
MBLY
$7.76B
| $543K | 0.92% |
13,067
| – | – |
|
25
ServiceNow
NOW
$106B
| $499K | 0.84% |
4,465
| – | – |
|
Similar funds
CF
DBFM
CAS
FH
RWFS
RFO
DWM
AGC
Brandywine Managers's Q3 2023 Portfolio in Review
As of Q3 2023, Brandywine Managers held 49 positions worth $59.3M, down 61% from $151M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Brandywine Managers withdrew a net $90.6M in Q3 2023, closing 11 positions and reducing 1 holding. Its most notable exit was Procter & Gamble, an estimated $23.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Brandywine Managers opened a new position in Structure Therapeutics worth $555K.
- Brandywine Managers's largest Q3 2023 buy was Structure Therapeutics: 11,000 shares worth $555K.
- Brandywine Managers added most to iShares MSCI ACWI ETF in Q3 2023, an estimated $1.65M increase.
- Brandywine Managers's biggest Q3 2023 reduction was Natera, cutting an estimated $153K.
- Brandywine Managers fully exited Procter & Gamble in Q3 2023, selling an estimated $23.9M.
- Brandywine Managers's ten largest holdings make up 76% of its $59.3M portfolio in Q3 2023.
- Brandywine Managers opened 1 new position and closed 11 in Q3 2023.
- Brandywine Managers's portfolio value fell 61% quarter-over-quarter to $59.3M.
Based on Brandywine Managers's 13F filing for Q3 2023, filed 14 Nov 2023.